Cargando…
Serum Antibody Activity against Poly-N-Acetyl Glucosamine (PNAG), but Not PNAG Vaccination Status, Is Associated with Protecting Newborn Foals against Intrabronchial Infection with Rhodococcus equi
Rhodococcus equi is a prevalent cause of pneumonia in foals worldwide. Our laboratory has demonstrated that vaccination against the surface polysaccharide β-1→6-poly-N-acetylglucosamine (PNAG) protects foals against intrabronchial infection with R. equi when challenged at age 28 days. However, it is...
Autores principales: | Cohen, Noah D., Kahn, Susanne K., Cywes-Bentley, Colette, Ramirez-Cortez, Sophia, Schuckert, Amanda E., Vinacur, Mariana, Bordin, Angela I., Pier, Gerald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552712/ https://www.ncbi.nlm.nih.gov/pubmed/34319137 http://dx.doi.org/10.1128/spectrum.00638-21 |
Ejemplares similares
-
Randomized, controlled trial comparing Rhodococcus equi and poly‐N
‐acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals
por: Kahn, Susanne K., et al.
Publicado: (2021) -
Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia
por: Kahn, Susanne K., et al.
Publicado: (2021) -
Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi
por: Cywes-Bentley, Colette, et al.
Publicado: (2018) -
Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi
por: Cohen, Noah D., et al.
Publicado: (2020) -
In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly‐N‐acetyl glucosamine hyperimmune plasma compared to commercial plasma products
por: Folmar, Chelsea N., et al.
Publicado: (2019)